ADAR1 Capital Management, LLC

Position in VKTX — Viking Therapeutics, Inc.

CIK 1940272 AUSTIN, TX

Position in VKTX

as of Mar 31, 2026 · filed May 18, 2026 Compact

Position Value

$7,409,911

+$6,477,853 QoQ

Shares Held

227,717

+759.5% QoQ

Ownership

0.196%

of shares outstanding

% of Portfolio

0.47%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2023

10 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

ADAR1 Capital Management, LLC holds $1,363,006,285 across 212 Biotechnology names. VKTX ranks #45 (0.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABVX	Abivax S.A.	1,394,019	$155,224,015
2	PTGX	Protagonist Therapeutics, Inc	994,119	$104,780,142
3	ROIV	Roivant Sciences Ltd.	3,285,906	$91,019,596
4	IMVT	Immunovant, Inc.	2,679,010	$66,546,608
5	TERN	Terns Pharmaceuticals, Inc.	914,699	$48,222,931
6	CYTK	Cytokinetics Inc	632,556	$41,691,765
7	CRNX	Crinetics Pharmaceuticals, Inc.	1,139,331	$41,380,501
8	DNLI	Denali Therapeutics Inc.	1,871,455	$35,931,936

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$7,409,911	227,717	+759.5%	Shares	Sole	2026-05-18
2025-12-31	$932,058	26,494	-84.9%	Shares	Sole	2026-02-18
2025-09-30	$4,623,151	175,919	+159.4%	Shares	Sole	2025-11-14
2025-06-30	$1,797,044	67,813	+14.1%	Shares	Sole	2025-08-14
2025-03-31	$1,434,823	59,413	+538.8%	Shares	Sole	2025-05-15
2024-12-31	$374,232	9,300	+31.0%	Shares	Sole	2025-02-13
2024-09-30	$449,501	7,100	-92.2%	Shares	Sole	2024-11-14
2024-06-30	$4,835,943	91,227	+533.5%	Shares	Sole	2024-08-13
2024-03-31	$1,180,882	14,401	-94.3%	Shares	Sole	2024-05-15
2023-12-31	$4,729,750	254,151	—	Shares	Sole	2024-02-14
No filing history on record for this holder in this stock.